Live zoster vaccine safe, effective in patients taking TNF inhibitors

ATLANTA — Data from the Varicella Zoster Vaccine study demonstrate that administering live, attenuated varicella vaccine to patients taking TNF inhibitors did not result in any safety events or disease flare after 6 weeks. In addition, there were no cases of varicella infection — either wild or vaccine type.“I’m very excited about the results of this long-planned and long in coming study,” Jeffrey Curtis, MD, a rheumatologist and clinical researcher at the University of Alabama at Birmingham, and Healio Rheumatology Peer Perspective Board member, said during aRead More